TY - JOUR AU - Chan, J. AU - Desai, A. K. AU - Kazi, Z. B. AU - Corey, K. AU - Austin, S. AU - Hobson-webb, L. D. PY - 2017 DA - 2017// TI - The emerging phenotype of late-onset Pompe disease : a systematic literature review JO - Mol Genet Metab VL - 120 UR - https://doi.org/10.1016/j.ymgme.2016.12.004 DO - 10.1016/j.ymgme.2016.12.004 ID - Chan2017 ER - TY - JOUR AU - Schoser, B. PY - 2019 DA - 2019// TI - Pompe disease : what are we missing ? JO - Ann Transl Med VL - 7 UR - https://doi.org/10.21037/atm.2019.05.29 DO - 10.21037/atm.2019.05.29 ID - Schoser2019 ER - TY - STD TI - Toscano A, Rodolico C, Musumeci O. Multisystem late onset Pompe disease ( LOPD ): an update on clinical aspects. Ann Transl Med. 2019;7(13):284. ID - ref3 ER - TY - JOUR AU - Lamartine, S. AU - Monteiro, M. AU - Remiche, G. PY - 2019 DA - 2019// TI - Late-onset Pompe disease associated with polyneuropathy JO - Neuromuscul Disord VL - 29 UR - https://doi.org/10.1016/j.nmd.2019.08.016 DO - 10.1016/j.nmd.2019.08.016 ID - Lamartine2019 ER - TY - JOUR AU - Remiche, G. AU - Herbaut, A. -. G. AU - Ronchi, D. AU - Lamperti, C. AU - Magri, F. AU - Moggio, M. PY - 2012 DA - 2012// TI - Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition JO - Eur Neurol VL - 68 UR - https://doi.org/10.1159/000338776 DO - 10.1159/000338776 ID - Remiche2012 ER - TY - JOUR AU - Hahn, A. AU - Schänzer, A. PY - 2019 DA - 2019// TI - Long-term outcome and unmet needs in infantile-onset Pompe disease JO - Ann Transl Med VL - 7 ID - Hahn2019 ER - TY - CHAP PY - 2019 DA - 2019// TI - Key figures 2019 BT - Looking at the facts [Internet] ID - ref7 ER - TY - BOOK AU - Erasmus, M. C. PY - 2019 DA - 2019// TI - Pompe disease GAA variants database [internet] ID - Erasmus2019 ER - TY - JOUR AU - Ploeg, A. T. AU - Kruijshaar, M. E. AU - Toscano, A. AU - Laforêt, P. AU - Angelini, C. AU - Lachmann, R. H. PY - 2017 DA - 2017// TI - European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience JO - Eur J Neurol VL - 24 UR - https://doi.org/10.1111/ene.13285 DO - 10.1111/ene.13285 ID - Ploeg2017 ER - TY - JOUR AU - Schoser, B. AU - Stewart, A. AU - Kanters, S. AU - Hamed, A. AU - Jansen, J. AU - Chan, K. PY - 2017 DA - 2017// TI - Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis JO - J Neurol VL - 264 UR - https://doi.org/10.1007/s00415-016-8219-8 DO - 10.1007/s00415-016-8219-8 ID - Schoser2017 ER - TY - JOUR AU - Vandervelde, L. AU - Bergh, P. Y. K. AU - Goemans, N. AU - Thonnard, J. L. PY - 2007 DA - 2007// TI - ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders JO - Neuromuscul Disord VL - 17 UR - https://doi.org/10.1016/j.nmd.2007.02.013 DO - 10.1016/j.nmd.2007.02.013 ID - Vandervelde2007 ER - TY - JOUR AU - Vandervelde, L. AU - Bergh, P. Y. K. AU - Goemans, N. AU - Thonnard, J. L. PY - 2009 DA - 2009// TI - Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire JO - Neuromuscul Disord VL - 19 UR - https://doi.org/10.1016/j.nmd.2008.11.004 DO - 10.1016/j.nmd.2008.11.004 ID - Vandervelde2009 ER - TY - JOUR AU - Batcho, C. S. AU - Bergh, P. Y. K. AU - Damme, P. AU - Roy, A. J. AU - Thonnard, J. -. L. AU - Penta, M. PY - 2016 DA - 2016// TI - How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases? JO - Neuromuscul Disord VL - 26 UR - https://doi.org/10.1016/j.nmd.2015.12.004 DO - 10.1016/j.nmd.2015.12.004 ID - Batcho2016 ER - TY - BOOK PY - 2007 DA - 2007// TI - Activlim - Instructions [Internet] ID - ref14 ER - TY - JOUR AU - Reuser, A. J. J. AU - Ploeg, A. T. AU - Chien, Y. H. AU - Llerena, J. AU - Abbott, M. A. AU - Clemens, P. R. PY - 2019 DA - 2019// TI - GAA variants and phenotypes among 1,079 patients with Pompe disease: data from the Pompe registry JO - Hum Mutat VL - 40 UR - https://doi.org/10.1002/humu.23878 DO - 10.1002/humu.23878 ID - Reuser2019 ER - TY - BOOK AU - Regression, H. F. PY - 2001 DA - 2001// TI - Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis PB - Springer CY - Verlag New York ID - Regression2001 ER - TY - JOUR AU - Schoser, B. AU - Laforêt, P. AU - Kruijshaar, M. E. AU - Toscano, A. AU - Doorn, P. A. AU - Ploeg, A. T. PY - 2015 DA - 2015// TI - 208th ENMC international workshop: formation of a European network to develop a European data sharing model and treatment guidelines for Pompe disease Naarden, the Netherlands, 26-28 September 2014 JO - Neuromuscul Disord VL - 25 UR - https://doi.org/10.1016/j.nmd.2015.04.006 DO - 10.1016/j.nmd.2015.04.006 ID - Schoser2015 ER - TY - JOUR AU - Löscher, W. N. AU - Huemer, M. AU - Stulnig, T. M. AU - Simschitz, P. AU - Iglseder, S. AU - Eggers, C. PY - 2018 DA - 2018// TI - Pompe disease in Austria: clinical, genetic and epidemiological aspects JO - J Neurol VL - 265 UR - https://doi.org/10.1007/s00415-017-8686-6 DO - 10.1007/s00415-017-8686-6 ID - Löscher2018 ER - TY - JOUR AU - Zhao, Y. AU - Wang, Z. AU - Lu, J. AU - Gu, X. AU - Huang, Y. AU - Qiu, Z. PY - 2019 DA - 2019// TI - Characteristics of Pompe disease in China: a report from the Pompe registry JO - Orphanet J Rare Dis VL - 14 UR - https://doi.org/10.1186/s13023-019-1054-0 DO - 10.1186/s13023-019-1054-0 ID - Zhao2019 ER - TY - JOUR AU - Nazari, F. AU - Sinaei, F. AU - Nilipour, Y. AU - Fatehi, F. AU - Streubel, B. AU - Ashrafi, M. R. PY - 2017 DA - 2017// TI - Late-onset pompe disease in Iran: a clinical and genetic report JO - Muscle Nerve VL - 55 UR - https://doi.org/10.1002/mus.25413 DO - 10.1002/mus.25413 ID - Nazari2017 ER - TY - JOUR AU - Montagnese, F. AU - Granata, F. AU - Musumeci, O. AU - Rodolico, C. AU - Mondello, S. AU - Barca, E. PY - 2016 DA - 2016// TI - Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) JO - J Inherit Metab Dis VL - 39 UR - https://doi.org/10.1007/s10545-015-9913-x DO - 10.1007/s10545-015-9913-x ID - Montagnese2016 ER - TY - JOUR AU - Musumeci, O. AU - Marino, S. AU - Granata, F. AU - Morabito, R. AU - Bonanno, L. AU - Brizzi, T. PY - 2019 DA - 2019// TI - Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis JO - Eur J Neurol VL - 26 UR - https://doi.org/10.1111/ene.13835 DO - 10.1111/ene.13835 ID - Musumeci2019 ER - TY - STD TI - Leslie N, Bailey L. Pompe Disease [Internet]. In: Adam M, Ardinger H, Pagon R, editors. GeneReviews®. Seattle (WA): University of Washington. [cited 2020 Jan 16]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1261/. UR - https://www.ncbi.nlm.nih.gov/books/NBK1261/ ID - ref23 ER - TY - JOUR AU - Thompson, B. G. AU - Brown, R. D. AU - Amin-Hanjani, S. AU - Broderick, J. P. AU - Cockroft, K. M. AU - Connolly, E. S. PY - 2015 DA - 2015// TI - Guidelines for the Management of Patients with Unruptured Intracranial Aneurysms JO - Stroke VL - 46 UR - https://doi.org/10.1161/STR.0000000000000070 DO - 10.1161/STR.0000000000000070 ID - Thompson2015 ER - TY - JOUR AU - Beek, N. A. AU - Hagemans, M. L. AU - Ploeg, A. T. AU - Doorn, P. A. AU - Merkies, I. S. PY - 2013 DA - 2013// TI - The Rasch-built Pompe-specific activity (R-PAct) scale JO - Neuromuscul Disord VL - 23 UR - https://doi.org/10.1016/j.nmd.2012.10.024 DO - 10.1016/j.nmd.2012.10.024 ID - Beek2013 ER - TY - JOUR AU - Lachmann, R. AU - Schoser, B. PY - 2013 DA - 2013// TI - The clinical relevance of outcomes used in late-onset Pompe disease: can we do better? JO - Orphanet J Rare Dis VL - 8 UR - https://doi.org/10.1186/1750-1172-8-160 DO - 10.1186/1750-1172-8-160 ID - Lachmann2013 ER - TY - JOUR AU - Vandervelde, L. AU - Bergh, P. Y. K. AU - Renders, A. AU - Goemans, N. AU - Thonnard, J. L. PY - 2009 DA - 2009// TI - Relationships between motor impairments and activity limitations in patients with neuromuscular disorders JO - J Neurol Neurosurg Psychiatry VL - 80 UR - https://doi.org/10.1136/jnnp.2008.150060 DO - 10.1136/jnnp.2008.150060 ID - Vandervelde2009 ER - TY - JOUR AU - Stepien, K. M. AU - Hendriksz, C. J. AU - Roberts, M. AU - Sharma, R. PY - 2016 DA - 2016// TI - Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5years JO - Mol Genet Metab VL - 117 UR - https://doi.org/10.1016/j.ymgme.2016.01.013 DO - 10.1016/j.ymgme.2016.01.013 ID - Stepien2016 ER - TY - JOUR AU - Toscano, A. AU - Schoser, B. PY - 2013 DA - 2013// TI - Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review JO - J Neurol VL - 260 UR - https://doi.org/10.1007/s00415-012-6636-x DO - 10.1007/s00415-012-6636-x ID - Toscano2013 ER - TY - JOUR AU - Kuperus, E. AU - Kruijshaar, M. E. AU - Wens, S. C. A. AU - Vries, J. M. AU - Favejee, M. M. AU - Meijden, J. C. PY - 2017 DA - 2017// TI - Long-term benefit of enzyme replacement therapy in Pompe disease JO - Neurology VL - 89 UR - https://doi.org/10.1212/WNL.0000000000004711 DO - 10.1212/WNL.0000000000004711 ID - Kuperus2017 ER - TY - JOUR AU - Crescimanno, G. AU - Modica, R. AU - Lo Mauro, R. AU - Musumeci, O. AU - Toscano, A. AU - Marrone, O. PY - 2015 DA - 2015// TI - Role of the cardio-pulmonary exercise test and six-minute walking test in the evaluation of exercise performance in patients with late-onset Pompe disease JO - Neuromuscul Disord VL - 25 UR - https://doi.org/10.1016/j.nmd.2015.03.010 DO - 10.1016/j.nmd.2015.03.010 ID - Crescimanno2015 ER - TY - JOUR AU - Harlaar, L. AU - Hogrel, J. -. Y. AU - Perniconi, B. AU - Kruijshaar, M. E. AU - Rizopoulos, D. AU - Taouagh, N. PY - 2019 DA - 2019// TI - Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease JO - Neurology VL - 93 UR - https://doi.org/10.1212/WNL.0000000000008441 DO - 10.1212/WNL.0000000000008441 ID - Harlaar2019 ER -